Efficacy of Direct-acting Antivirals in Hemodialysis Patients with Chronic Hepatitis C: A Real-life Retrospective Study

AYDIN N. N., AKSOY F., YAVUZ İ., Iskender S., YILDIRIM A. A., Yildiz I. E., ...More

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.25, no.3, pp.105-108, 2019 (ESCI) identifier


Objectives: Hepatitis C virus (HCV) infection is common among hemodialysis (HD) patients and is associated with increased morbidity and mortality. New generation direct-acting antiviral (DAA) agents are safe and effective in treatment HCV infection in HD patients. The aim of this a multi-center study was to assess the efficacy of DAAs in HD patients with HCV infection.